4 June 2024 in Journal of the American Chemical Society
6 December 2023 in Journal of the American Chemical Society
23 February 2026 in Journal of the American Chemical Society
We report the synthesis and characterization of a small molecule, CP-20, capable of inhibiting the key quorum sensing receptor AgrC in Staphylococcus aureus. Structural alterations enabled the discovery of a CP-20 derivative that is capable of complete quorum sensing inhibition with mid-nanomolar potency. In vitro biochemical investigations support CP-20 binding AgrC and competitively inhibiting its activity. CP-20 represents a versatile and synthetically tractable small molecule probe for investigating Staphylococcal virulence via quorum sensing modulation.
23 September 2026 in ACS Infectious Diseases
The accessory gene regulator (agr) quorum-sensing system in Staphylococcus aureus plays a prominent role in acute infections caused by this common pathogen. In contrast, ATP synthase affects the ability of S. aureus to establish chronic infections and persist as small colony variants. In this study, we report that a synthetic small molecule, CP-20, is capable of dually inhibiting agr and ATP synthase. We demonstrate CP-20’s ability to counteract key virulence phenotypes associated with both pathways, including hemolysis, biofilm formation, and antibiotic resistance. We also show that CP-20 facilitates more efficient clearance of S. aureus by murine macrophages than genetic inactivation of either agr or ATP synthase alone, suggesting that dual inhibition may have an additive effect on ablating intracellular survival. This work demonstrates the utility of a single chemical modulator to attenuate S. aureus pathogenesis via two nonessential pathways and suggests a pathway toward nonbactericidal virulence control.
15 April 2026 in Biochemistry
Many questions remain about the biochemical mechanisms of quorum sensing (QS), particularly in Gram-positive bacterial pathogens that pose serious threats to human health such as Staphylococcus aureus. Methods to isolate and study the molecular components of these signaling systems in vitro are not straightforward. To date, most mechanistic investigations into QS systems have been accomplished in cells and, to a lesser extent, using chemical inhibitors. Herein, we report the development and characterization of a set of engineered Bacillus subtilis strains that can be used to study the accessory gene regulator (agr) QS circuits of a variety of Gram-positive bacteria. We cloned the S. aureus agr QS machinery into B. subtilis as proof-of-concept to generate "sender" cells capable of autoinducing peptide (AIP) signal biosynthesis, "receiver" cells capable of signal transduction, and "full" cells containing the full agr QS system. We verified that the B. subtilis sender cells could produce the native S. aureus AIP and that the receiver and full cells responded to both the AIP signal and a panel of known chemical agr modulators. The approach was readily transferable to study the agr QS systems of Staphylococcus epidermidis and Listeria monocytogenes, revealing interesting differences that could indicate underlying divergences in native QS mechanisms. We also demonstrate the ability of these B. subtilis strains to function as biosensors to detect the native AIPs of bacteria and produce a targeted antibiotic in response. These engineered systems should find utility for the study of QS in a range of fundamental and applied contexts.